Abstract
Plasma cells are professional secretory cells, which function as cellular factories for immunoglobulin synthesis and secretion. Being the sole cell type responsible for antibody secretion they play an essential role in the immune response against a broad spectrum of pathogens. Since plasma cells have a long life span and are able to secrete copious amounts of antibody, their number and repertoire should be tightly regulated. Disruption of their homeostasis may lead to severe diseases, such as immunodeficiency or multiple myeloma. Much of the complications of multiple myeloma are attributed to the antibodies themselves, which accumulate in the bloodstream and lead to kidney and pulmonary insufficiencies. Similar pathologies are common to other plasma cell-related diseases, such as AL amyloidosis and autoimmune diseases, in which Ig molecules accumulate to toxic levels without good means to curtail their production. The process of plasma cell differentiation and maintenance is poorly understood. The discovery that the IRE1/XBP-1 arm of the unfolded protein response (UPR) is necessary to yield full-fledged plasma cells in vivo was a breakthrough in the field. Over the years valuable biochemical information on plasma cell differentiation was obtained by exploring the downstream activities of XBP-1. The most pronounced phenotype of XBP-1 deficiency in plasma cells in vitro is the steep reduction in μ chain synthesis albeit similar levels of its mRNA. Remarkably, the defect is specific to Ig heavy chains as synthesis of other glycoproteins remains normal. Furthermore, when XBP-1 is absent or its mRNA splicing is inhibited the efficiency of protein translocation into the ER is severely impaired. Still, fundamental questions remain unanswered, such as what exactly generates the conditions of endoplasmic reticulum (ER) stress that activates the UPR in the developing plasma cells. Another enigma is how lipid biosynthesis and protein synthesis, both dramatically modulated during differentiation, are coordinated. In this chapter, we will provide detailed methodologies for measurements of Ig synthesis and misinsertion into the ER as readout of ER physiology in the course of plasma cell differentiation.
Original language | English |
---|---|
Title of host publication | Methods in Enzymology |
Publisher | Academic Press Inc. |
Pages | 309-325 |
Number of pages | 17 |
DOIs | |
State | Published - 2011 |
Publication series
Name | Methods in Enzymology |
---|---|
Volume | 491 |
ISSN (Print) | 0076-6879 |
Bibliographical note
Funding Information:BT is affiliated with the David R. Bloom Center for Pharmacy at the Hebrew University (Jerusalem, Israel), and with the Dr. Adolf and Klara Brettler Centre for Research in Molecular Pharmacology and Therapeutics at the Hebrew University. The authors declare no financial conflict of interest. Research was funded by grants from David R. Bloom Center for Pharmacy, the Rosetrees fund, the Lower Saxony Research Fund, and Israel Science Foundation grant no. 78/09.